Healthcare · Vaccine antigens production

Vaccine antigens production in Norway in 2026

Norway does not produce vaccine antigens — the indicator is 10 million doses. The country lacks large-scale manufacturing facilities for vaccines, focusing instead on importing finished products and developing biotechnological research. Instead, Norway actively invests in developing new treatments and diagnostics, especially in oncology and rare diseases.

Data for 2026 · unit: million doses
Position

Norway world ranking

#17 / 197

Country position on the scale from last to first place for this indicator.

NO
#17
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
8
1990
15
2000
10
2010
20
2020
10
2025
10
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Norway — how much?
Based on 2026 data — 10 million doses. This is rank #17 out of 197 countries.
What is Norway's rank by Vaccine antigens production?
Norway ranks #17 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Norway?
Over the available period the indicator changed from 1 to 10 million doses.